Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BSQUARE CORP /WA
Report date December 08, 2023 · Filed December 08, 2023
Section 16 reporting ended · disclosed 2023-12-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-12-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-12-08 · Disposition to issuer · Disposed 137,094 · Balance 17,307 F1: In connection with that certain Agreement and Plan of Merger by and among BSQUARE Corporation, a Washington corporation (the "Company"), Kontron America, Incorporated, a Delaware corporation, and Kontron MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Kontron, dated as of October 11, 2023 (the "Merger Agreement") and the related tender offer, Ryan L. Vardeman (the "Reporting Person") became entitled to receive, in respect of each share of the Company's Common Stock, an amount in cash equal to $1.90 per share (the "Offer Price"). F2: The Merger Agreement provides that, subject to any required withholding taxes, at the effective time of the Merger, each time-based restricted stock unit with respect to shares of Common Stock of the Company (each a "Company RSU") that is then outstanding and vested will be cancelled and the holder of such Company RSU will be entitled to receive a cash payment equal to the product of (i) the Offer Price and (ii) the number of shares of Common Stock of the Company subject to such Company RSU. Row 2 · 2023-12-08 · Disposition to issuer · Disposed 17,307 · Balance 0 F3: The Merger Agreement provides that at the effective time of the Merger, each then outstanding and unvested Company RSU shall be cancelled without payment of consideration, and all rights with respect to such unvested Company RSU shall terminate at such time. |
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2023-12-08 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2023-12-08 · Disposition to issuer · Disposed 1,585,711 · Balance 0 F1: In connection with that certain Agreement and Plan of Merger by and among BSQUARE Corporation, a Washington corporation (the "Company"), Kontron America, Incorporated, a Delaware corporation, and Kontron MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Kontron, dated as of October 11, 2023 (the "Merger Agreement") and the related tender offer, Ryan L. Vardeman (the "Reporting Person") became entitled to receive, in respect of each share of the Company's Common Stock, an amount in cash equal to $1.90 per share (the "Offer Price"). F2: The Merger Agreement provides that, subject to any required withholding taxes, at the effective time of the Merger, each time-based restricted stock unit with respect to shares of Common Stock of the Company (each a "Company RSU") that is then outstanding and vested will be cancelled and the holder of such Company RSU will be entitled to receive a cash payment equal to the product of (i) the Offer Price and (ii) the number of shares of Common Stock of the Company subject to such Company RSU. F4: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities coverted by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F5: The Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise (the "Exchange Act"), the beneficial owner of any securities covered by this statement. The Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the Reporting Person in such securities. F6: The Reporting Person may be deemed to be a member of a group with respect to the Company or securities of the Company for purposes of Section 13(d) or 13(g) of the Exchange Act. The Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Company or securities of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: In connection with that certain Agreement and Plan of Merger by and among BSQUARE Corporation, a Washington corporation (the "Company"), Kontron America, Incorporated, a Delaware corporation, and Kontron MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Kontron, dated as of October 11, 2023 (the "Merger Agreement") and the related tender offer, Ryan L. Vardeman (the "Reporting Person") became entitled to receive, in respect of each share of the Company's Common Stock, an amount in cash equal to $1.90 per share (the "Offer Price").
F2: The Merger Agreement provides that, subject to any required withholding taxes, at the effective time of the Merger, each time-based restricted stock unit with respect to shares of Common Stock of the Company (each a "Company RSU") that is then outstanding and vested will be cancelled and the holder of such Company RSU will be entitled to receive a cash payment equal to the product of (i) the Offer Price and (ii) the number of shares of Common Stock of the Company subject to such Company RSU.
F3: The Merger Agreement provides that at the effective time of the Merger, each then outstanding and unvested Company RSU shall be cancelled without payment of consideration, and all rights with respect to such unvested Company RSU shall terminate at such time.
F4: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities coverted by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
F5: The Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise (the "Exchange Act"), the beneficial owner of any securities covered by this statement. The Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the Reporting Person in such securities.
F6: The Reporting Person may be deemed to be a member of a group with respect to the Company or securities of the Company for purposes of Section 13(d) or 13(g) of the Exchange Act. The Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Company or securities of the Company.
INTEVAC INC
Report date March 31, 2025 · Filed April 01, 2025
Section 16 reporting ended · disclosed 2025-04-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2025-03-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-03-31 · Other · Disposed 1,053,924 · Balance 0 F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among Seagate Technology Holdings plc, the Issuer and Irvine Acquisition Holdings, Inc., dated as of February 13, 2025, the reported securities were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Offer Consideration"). F5: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F6: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934. F7: The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934 or any other purpose, a member of a group with respect to the issuer or securities of the issuer. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-31 transaction · row 2
1 source rowRow 2 · 2025-03-31 · Disposition to issuer · Disposed 12,000 · Balance 0 F2: At the Effective Time (as defined in the Merger Agreement), pursuant to the Merger Agreement, each restricted stock unit of the Issuer that vested based solely on the continued performance of services and performance metrics (each, a "Company RSU") then outstanding, whether or not vested, was cancelled in exchange for a cash payment equal to (x) the total numbers of shares subject to such Company RSU immediately prior to the Effective Time (without regard to vesting) multiplied by (y) the Offer Consideration. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.55 · Expires 2031-11-12 | Direct | 0 |
Reported balance
After 2025-03-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-03-31 · Disposition to issuer · Disposed 10,300 · Balance 0 F4: At the Effective Time, pursuant to the Merger Agreement, each In-the-Money Option that was then outstanding was cancelled in exchange for an amount in cash equal to the product of (x) the total number of shares subject to such In-the-Money Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Offer Consideration over the applicable exercise price per share of such In-the-Money Option. F3: At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase shares of common stock of the Issuer having an exercise price per share that was less than the Offer Consideration (each, an "In-the-Money Option") that was then outstanding and unvested as of immediately prior to the Effective Time vested in full. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among Seagate Technology Holdings plc, the Issuer and Irvine Acquisition Holdings, Inc., dated as of February 13, 2025, the reported securities were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Offer Consideration").
F2: At the Effective Time (as defined in the Merger Agreement), pursuant to the Merger Agreement, each restricted stock unit of the Issuer that vested based solely on the continued performance of services and performance metrics (each, a "Company RSU") then outstanding, whether or not vested, was cancelled in exchange for a cash payment equal to (x) the total numbers of shares subject to such Company RSU immediately prior to the Effective Time (without regard to vesting) multiplied by (y) the Offer Consideration.
F3: At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase shares of common stock of the Issuer having an exercise price per share that was less than the Offer Consideration (each, an "In-the-Money Option") that was then outstanding and unvested as of immediately prior to the Effective Time vested in full.
F4: At the Effective Time, pursuant to the Merger Agreement, each In-the-Money Option that was then outstanding was cancelled in exchange for an amount in cash equal to the product of (x) the total number of shares subject to such In-the-Money Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Offer Consideration over the applicable exercise price per share of such In-the-Money Option.
F5: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
F6: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934.
F7: The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934 or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
LIVEPERSON INC
Report date September 04, 2026 · Filed September 04, 2026
Section 16 reporting ended · disclosed 2026-09-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2026-09-04 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-04 · Disposition to issuer · Disposed 44,422 · Balance 0 F1: On September 4, 2026, pursuant to the terms of the Amended and Restated Merger Agreement, dated as of July 2, 2026 (the "Merger Agreement"), by and among the Issuer, SoundHound AI, Inc., a Delaware corporation ("Parent"), Lightspeed Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), and Lightspeed Merger Sub II Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub II"), Merger Sub merged with and into the Issuer and immediately thereafter, Merger Sub II merged with and into the Issuer, with the Issuer continuing as the surviving corporation as an indirect wholly owned subsidiary of Parent (the "Mergers"). F2: In connection with the Mergers, each share of Issuer common stock was cancelled and converted into the right to receive 0.4673 fully paid and nonassessable shares of Parent's Class A common stock (the "Per Share Merger Consideration"), subject to the terms and conditions of the Merger Agreement. F3: The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that the reporting person is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. F4: The reporting person declares that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended. F5: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-09-04 transaction · row 2
1 source rowRow 2 · 2026-09-04 · Disposition to issuer · Disposed 23,350 · Balance 0 F6: Represents 23,350 restricted stock units previously awarded by the Issuer ("Company RSUs") and held by the reporting person immediately prior to the First Effective Time (as defined in the Merger Agreement). F7: Pursuant to the Merger Agreement, at the First Effective Time, these Company RSUs were cancelled and converted into the right to receive the Per Share Merger Consideration, subject to the terms and conditions of the Merger Agreement, in respect of each share of Issuer common stock subject to such Company RSU. |
| 0% Convertible Senior Notes due 2026SEC Table II · derivative / convertible security · Conversion / exercise price $1,128.39 · Expires 2026-12-15 | IndirectSee Footnotes (3)(4)(5) | 0 |
Reported balance
After 2026-09-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-04 · Sale · Disposed 3,456 · Balance 0 F8: Following the closing of the merger of the Issuer with and into SoundHound AI, Inc., Palogic Value Fund sold $3.9 million aggregate principal amount of the Issuer's 0% Convertible Senior Notes due 2026 to the Issuer at a price of $3.12 million. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 4, 2026, pursuant to the terms of the Amended and Restated Merger Agreement, dated as of July 2, 2026 (the "Merger Agreement"), by and among the Issuer, SoundHound AI, Inc., a Delaware corporation ("Parent"), Lightspeed Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), and Lightspeed Merger Sub II Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub II"), Merger Sub merged with and into the Issuer and immediately thereafter, Merger Sub II merged with and into the Issuer, with the Issuer continuing as the surviving corporation as an indirect wholly owned subsidiary of Parent (the "Mergers").
F2: In connection with the Mergers, each share of Issuer common stock was cancelled and converted into the right to receive 0.4673 fully paid and nonassessable shares of Parent's Class A common stock (the "Per Share Merger Consideration"), subject to the terms and conditions of the Merger Agreement.
F3: The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that the reporting person is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer.
F4: The reporting person declares that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.
F5: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
F6: Represents 23,350 restricted stock units previously awarded by the Issuer ("Company RSUs") and held by the reporting person immediately prior to the First Effective Time (as defined in the Merger Agreement).
F7: Pursuant to the Merger Agreement, at the First Effective Time, these Company RSUs were cancelled and converted into the right to receive the Per Share Merger Consideration, subject to the terms and conditions of the Merger Agreement, in respect of each share of Issuer common stock subject to such Company RSU.
F8: Following the closing of the merger of the Issuer with and into SoundHound AI, Inc., Palogic Value Fund sold $3.9 million aggregate principal amount of the Issuer's 0% Convertible Senior Notes due 2026 to the Issuer at a price of $3.12 million.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 4, 2026 20:13 UTC | LIVEPERSON INC LPSN · Entity 7365 | Sale0% Convertible Senior Notes due 2026 · Derivative | 3,456 | $0.00 Strike: $1,128.39 | $0.00 |
DisclosureSEC source: 0001574629-26-000002 · wk-form4_1788552798.xml · derivative · entry 3 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes (3)(4)(5) Disclosed balance after: 0 Underlying: Common Stock · 3,456 shares Expires 2026-12-15 F8 · price: Following the closing of the merger of the Issuer with and into SoundHound AI, Inc., Palogic Value Fund sold $3.9 million aggregate principal amount of the Issuer's 0% Convertible Senior Notes due 2026 to the Issuer at a price of $3.12 million. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 20:13 UTC | LIVEPERSON INC LPSN · Entity 7365 | Disposition to issuerCommon Stock | 23,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001574629-26-000002 · wk-form4_1788552798.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F6 · price: Represents 23,350 restricted stock units previously awarded by the Issuer ("Company RSUs") and held by the reporting person immediately prior to the First Effective Time (as defined in the Merger Agreement). F7 · price: Pursuant to the Merger Agreement, at the First Effective Time, these Company RSUs were cancelled and converted into the right to receive the Per Share Merger Consideration, subject to the terms and conditions of the Merger Agreement, in respect of each share of Issuer common stock subject to such Company RSU. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 20:13 UTC | LIVEPERSON INC LPSN · Entity 7365 | Disposition to issuerCommon Stock | 44,422 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001574629-26-000002 · wk-form4_1788552798.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · price: On September 4, 2026, pursuant to the terms of the Amended and Restated Merger Agreement, dated as of July 2, 2026 (the "Merger Agreement"), by and among the Issuer, SoundHound AI, Inc., a Delaware corporation ("Parent"), Lightspeed Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), and Lightspeed Merger Sub II Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub II"), Merger Sub merged with and into the Issuer and immediately thereafter, Merger Sub II merged with and into the Issuer, with the Issuer continuing as the surviving corporation as an indirect wholly owned subsidiary of Parent (the "Mergers"). F2 · price: In connection with the Mergers, each share of Issuer common stock was cancelled and converted into the right to receive 0.4673 fully paid and nonassessable shares of Parent's Class A common stock (the "Per Share Merger Consideration"), subject to the terms and conditions of the Merger Agreement. F3 · ownership.nature: The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that the reporting person is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. F4 · ownership.nature: The reporting person declares that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended. F5 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:13 UTC | LIVEPERSON INC LPSN · Entity 7365 | GrantCommon Stock | 23,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001574629-25-000010 · wk-form4_1765574021.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,350 F1 · shares: The reporting person was granted an award of restricted stock units under the terms of the LivePerson, Inc. 2019 Stock Incentive Plan consisting of a grant of 23,350 restricted stock units (the "RSUs"), each of which represents a contingent right to receive one share of common stock of the issuer. These RSUs will fully vest on December 10, 2026. F2 · balance_after: Number reported includes 23,350 unvested restricted stock units granted to and held by the reporting person following the reported transaction. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 17:02 UTC | INTEVAC INC IVAC · Entity 81388 | Disposition to issuerStock Option (right to buy) · Derivative | 10,300 | Not disclosed Strike: $2.55 | Not disclosed |
DisclosureSEC source: 0000950170-25-048690 · ownership.xml · derivative · entry 3 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,300 shares Expires 2031-11-12 F4 · price: At the Effective Time, pursuant to the Merger Agreement, each In-the-Money Option that was then outstanding was cancelled in exchange for an amount in cash equal to the product of (x) the total number of shares subject to such In-the-Money Option immediately prior to the Effective Time multiplied by (y) the excess of the amount of the Offer Consideration over the applicable exercise price per share of such In-the-Money Option. F3 · derivative.exercise_date: At the Effective Time, pursuant to the Merger Agreement, each outstanding option to purchase shares of common stock of the Issuer having an exercise price per share that was less than the Offer Consideration (each, an "In-the-Money Option") that was then outstanding and unvested as of immediately prior to the Effective Time vested in full. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 17:02 UTC | INTEVAC INC IVAC · Entity 81388 | Disposition to issuerCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-048690 · ownership.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · shares: At the Effective Time (as defined in the Merger Agreement), pursuant to the Merger Agreement, each restricted stock unit of the Issuer that vested based solely on the continued performance of services and performance metrics (each, a "Company RSU") then outstanding, whether or not vested, was cancelled in exchange for a cash payment equal to (x) the total numbers of shares subject to such Company RSU immediately prior to the Effective Time (without regard to vesting) multiplied by (y) the Offer Consideration. F2 · price: At the Effective Time (as defined in the Merger Agreement), pursuant to the Merger Agreement, each restricted stock unit of the Issuer that vested based solely on the continued performance of services and performance metrics (each, a "Company RSU") then outstanding, whether or not vested, was cancelled in exchange for a cash payment equal to (x) the total numbers of shares subject to such Company RSU immediately prior to the Effective Time (without regard to vesting) multiplied by (y) the Offer Consideration. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 17:02 UTC | INTEVAC INC IVAC · Entity 81388 | OtherCommon Stock | 1,053,924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-048690 · ownership.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · shares: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among Seagate Technology Holdings plc, the Issuer and Irvine Acquisition Holdings, Inc., dated as of February 13, 2025, the reported securities were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Offer Consideration"). F1 · price: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), by and among Seagate Technology Holdings plc, the Issuer and Irvine Acquisition Holdings, Inc., dated as of February 13, 2025, the reported securities were tendered prior to the Expiration Date (as defined in the Merger Agreement) and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for $4.00 per share, payable in cash at closing, without interest and subject to reduction for any applicable withholding of taxes (the "Offer Consideration"). F5 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F6 · ownership.nature: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934. F7 · ownership.nature: The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934 or any other purpose, a member of a group with respect to the issuer or securities of the issuer. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 10:14 UTC | INTEVAC INC IVAC · Entity 81388 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,300 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001806637-24-000028 · primary_doc.xml · derivative · entry 3 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,300 Underlying: Intevac Common Stock · 10,300 shares Expires 2031-11-21 F5 · derivative.exercise_date: This option shall be exercisable, in whole or in part on May 15, 2025. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 10:14 UTC | INTEVAC INC IVAC · Entity 81388 | GrantIntevac Common Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001806637-24-000028 · primary_doc.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 F1 · shares: These are restricted stock units awarded to the Reporting Person and each restricted stock unit represents a contingent right to receive one share of IVAC common stock. The restricted stock units will vest on 5/15/2025. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 16:26 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | Disposition to issuerCommon Stock | 1,585,711 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-022216 · form4.xml · nonDerivative · entry 3 Vardeman Ryan L. · CIK 0001574629 · Former Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · shares: In connection with that certain Agreement and Plan of Merger by and among BSQUARE Corporation, a Washington corporation (the "Company"), Kontron America, Incorporated, a Delaware corporation, and Kontron MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Kontron, dated as of October 11, 2023 (the "Merger Agreement") and the related tender offer, Ryan L. Vardeman (the "Reporting Person") became entitled to receive, in respect of each share of the Company's Common Stock, an amount in cash equal to $1.90 per share (the "Offer Price"). F2 · shares: The Merger Agreement provides that, subject to any required withholding taxes, at the effective time of the Merger, each time-based restricted stock unit with respect to shares of Common Stock of the Company (each a "Company RSU") that is then outstanding and vested will be cancelled and the holder of such Company RSU will be entitled to receive a cash payment equal to the product of (i) the Offer Price and (ii) the number of shares of Common Stock of the Company subject to such Company RSU. F1 · price: In connection with that certain Agreement and Plan of Merger by and among BSQUARE Corporation, a Washington corporation (the "Company"), Kontron America, Incorporated, a Delaware corporation, and Kontron MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Kontron, dated as of October 11, 2023 (the "Merger Agreement") and the related tender offer, Ryan L. Vardeman (the "Reporting Person") became entitled to receive, in respect of each share of the Company's Common Stock, an amount in cash equal to $1.90 per share (the "Offer Price"). F4 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities coverted by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F5 · ownership.nature: The Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise (the "Exchange Act"), the beneficial owner of any securities covered by this statement. The Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the Reporting Person in such securities. F6 · ownership.nature: The Reporting Person may be deemed to be a member of a group with respect to the Company or securities of the Company for purposes of Section 13(d) or 13(g) of the Exchange Act. The Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Company or securities of the Company. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 16:26 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | Disposition to issuerCommon Stock | 17,307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-022216 · form4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F3 · shares: The Merger Agreement provides that at the effective time of the Merger, each then outstanding and unvested Company RSU shall be cancelled without payment of consideration, and all rights with respect to such unvested Company RSU shall terminate at such time. F3 · price: The Merger Agreement provides that at the effective time of the Merger, each then outstanding and unvested Company RSU shall be cancelled without payment of consideration, and all rights with respect to such unvested Company RSU shall terminate at such time. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 16:26 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | Disposition to issuerCommon Stock | 137,094 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-23-022216 · form4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,307 F1 · shares: In connection with that certain Agreement and Plan of Merger by and among BSQUARE Corporation, a Washington corporation (the "Company"), Kontron America, Incorporated, a Delaware corporation, and Kontron MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Kontron, dated as of October 11, 2023 (the "Merger Agreement") and the related tender offer, Ryan L. Vardeman (the "Reporting Person") became entitled to receive, in respect of each share of the Company's Common Stock, an amount in cash equal to $1.90 per share (the "Offer Price"). F2 · shares: The Merger Agreement provides that, subject to any required withholding taxes, at the effective time of the Merger, each time-based restricted stock unit with respect to shares of Common Stock of the Company (each a "Company RSU") that is then outstanding and vested will be cancelled and the holder of such Company RSU will be entitled to receive a cash payment equal to the product of (i) the Offer Price and (ii) the number of shares of Common Stock of the Company subject to such Company RSU. F1 · price: In connection with that certain Agreement and Plan of Merger by and among BSQUARE Corporation, a Washington corporation (the "Company"), Kontron America, Incorporated, a Delaware corporation, and Kontron MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Kontron, dated as of October 11, 2023 (the "Merger Agreement") and the related tender offer, Ryan L. Vardeman (the "Reporting Person") became entitled to receive, in respect of each share of the Company's Common Stock, an amount in cash equal to $1.90 per share (the "Offer Price"). Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 21:35 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | GrantCommon Stock | 23,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-013888 · form4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Chairman of the Board · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,401 F1 · shares: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F2 · balance_after: Includes 23,076 restricted stock units of the Issuer awarded to Ryan L. Vardeman on June 15, 2023 pursuant to the Issuer's compensation plan for non-employee directors and the Plan which will vest quarterly in equal installments over one year following the date of the award. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 17:56 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | GrantCommon Stock | 23,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-015963 · form4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,325 F1 · shares: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F2 · balance_after: Includes 23,076 restricted stock units of the Issuer awarded to Ryan L. Vardeman on June 30, 2022 pursuant to the Issuer's compensation plan for non-employee directors and the Plan which will vest quarterly in equal installments over one year following the date of the award. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 18:39 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | GrantCommon Stock, No Par Value | 23,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-005678 · form4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,249 F1 · shares: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F1 · price: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F2 · balance_after: Includes 23,076 restricted stock units of the Issuer awarded to Ryan L. Vardeman on June 10, 2021 pursuant to the Issuer's compensation plan for non-employee directors and the Plan which will vest quarterly in equal installments over one year following the date of the award. F3 · ownership.direct: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities coverted by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.direct: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. F5 · ownership.direct: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 11:54 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 21,115 | $1.45 | $30,580.85 |
DisclosureSEC source: 0000899243-20-023569 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,585,711 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.395 to $1.45 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 16:25 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 3,773 | $1.35 | $5,089.02 |
DisclosureSEC source: 0000899243-20-023202 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,564,596 F6 · price: This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.34 to $1.35 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: (Continued from Footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 16:25 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 25,112 | $1.34 | $33,748.02 |
DisclosureSEC source: 0000899243-20-023202 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,560,823 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.33 to $1.35 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: (Continued from Footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 21:52 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | GrantCommon Stock, No Par Value | 33,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001572426-20-000086 · edgar.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,173 F1 · shares: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F1 · price: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F2 · balance_after: Includes 33,784 restricted stock units of the Issuer awarded to Ryan L. Vardeman on July 17, 2020 pursuant to the Issuer's compensation plan for non-employee directors and the Plan which will vest quarterly in equal installments over one year following the date of the award. F3 · ownership.direct: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities coverted by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.direct: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. F5 · ownership.direct: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| May 18, 2020 Filed May 19, 2020 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 40,000 | $1.20 | $47,824.00 |
DisclosureSEC source: 0000899243-20-013560 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,535,711 F6 · price: This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.14 to $1.20 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: (Continued from Footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| May 15, 2020 Filed May 19, 2020 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 27,296 | $1.10 | $29,984.66 |
DisclosureSEC source: 0000899243-20-013560 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,495,711 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.085 to $1.13 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: (Continued from Footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 15,200 | $1.02 | $15,557.20 |
DisclosureSEC source: 0000899243-20-008431 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,468,415 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.002 to $1.03 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: (Continued from footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 32,900 | $1.18 | $38,733.17 |
DisclosureSEC source: 0000899243-20-007881 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,453,215 F6 · price: This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.17 to $1.18 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. F3 · ownership.nature: (Continued from Footnote 2) Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 35,787 | $1.20 | $42,933.66 |
DisclosureSEC source: 0000899243-20-007881 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,420,315 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.192 to $1.20 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. F3 · ownership.nature: (Continued from Footnote 2) Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 21,020 | $1.24 | $26,094.23 |
DisclosureSEC source: 0000899243-20-007607 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,384,528 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.22 to $1.25 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. F3 · ownership.nature: (Continued from Footnote 2) Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 16:07 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 10,000 | $1.25 | $12,456.00 |
DisclosureSEC source: 0000899243-20-006943 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,363,508 F6 · price: This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.21 to $1.25 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. F3 · ownership.nature: (continued from Footnote 2) Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 16:07 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 10,761 | $1.24 | $13,309.20 |
DisclosureSEC source: 0000899243-20-006943 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,353,508 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.21 to $1.25 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. F3 · ownership.nature: (continued from Footnote 2) Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 16:06 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 23,687 | $1.22 | $29,007.10 |
DisclosureSEC source: 0000899243-20-006472 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,342,747 F6 · price: This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.21 to $1.25 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: (Continued from footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 16:06 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 33,714 | $1.22 | $41,131.08 |
DisclosureSEC source: 0000899243-20-006472 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,319,060 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.205 to $1.225 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: (Continued from footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 16:25 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 33,132 | $1.28 | $42,541.49 |
DisclosureSEC source: 0000899243-19-027785 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,285,346 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.265 to $1.30 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. F3 · ownership.nature: (continued from footnote 2) Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| November 13, 2019 Filed Nov 14, 2019 20:10 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 26,016 | $1.29 | $33,560.64 |
DisclosureSEC source: 0000899243-19-027319 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,252,214 F6 · price: This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.25 to $1.30 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman, Palogic Value Fund, Palogic Value Management and Palogic Capital Management are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. F3 · ownership.nature: (continued from footnote 2) Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 20:10 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 40,852 | $1.28 | $52,290.56 |
DisclosureSEC source: 0000899243-19-027319 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director · Member of 10% Group Palogic Value Fund, LP · CIK 0001387846 · Member of 10% Group Palogic Value Management, L.P. · CIK 0001532943 · Member of 10% Group Palogic Capital Management, LLC · CIK 0001494018 · Member of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,226,198 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.25 to $1.29 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman, Palogic Value Fund, Palogic Value Management and Palogic Capital Management are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. F3 · ownership.nature: (continued from footnote 2) Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.nature: The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities. F5 · ownership.nature: The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer. Read SEC document |
| September 13, 2019 Filed Sep 16, 2019 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 10,484 | $1.29 | $13,534.84 |
DisclosureSEC source: 0000899243-19-023624 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,185,346 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.265 to $1.30 per Share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 17:11 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 1,837 | $1.25 | $2,296.25 |
DisclosureSEC source: 0000899243-19-023020 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,174,862 F1 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F2 · ownership.nature: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 17:11 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 26,525 | $1.25 | $33,156.25 |
DisclosureSEC source: 0000899243-19-023020 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,173,025 F1 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F2 · ownership.nature: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 15:55 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | GrantCommon Stock, No Par Value | 34,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036716 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,389 F1 · shares: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F1 · price: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F2 · balance_after: Includes 4,167 restricted stock units of the Issuer awarded to Ryan L. Vardeman on June 25, 2018 pursuant to the Issuer's compensation plan for non-employee directors and the Plan which will vest on June 25, 2019, and includes 34,722 restricted stock units of the Issuer awarded to Ryan L. Vardeman on June 11, 2019 pursuant to the Issuer's compensation plan for non-employee directors and the Plan which will vest quarterly in equal installments over one year following the date of the award. F3 · ownership.direct: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F4 · ownership.direct: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| May 17, 2019 Filed May 20, 2019 16:08 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 38,795 | $1.50 | $58,014.04 |
DisclosureSEC source: 0000899243-19-014131 · doc4.xml · nonDerivative · entry 2 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,146,500 F4 · price: This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.44 to $1.51 per Share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| May 16, 2019 Filed May 20, 2019 16:08 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 61,205 | $1.51 | $92,199.21 |
DisclosureSEC source: 0000899243-19-014131 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,107,705 F1 · price: This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.46 to $1.51 per Share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price. F2 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.nature: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 16:05 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | PurchaseCommon Stock, No Par Value | 98,000 | $1.95 | $191,100.00 |
DisclosureSEC source: 0000899243-18-022873 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,046,500 F1 · ownership.nature: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F2 · ownership.nature: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 16:10 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0000899243-18-018305 · doc4.xml · derivative · entry 3 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock, No Par Value · 25,000 shares Expires 2028-06-25 F5 · price: Granted to Mr. Vardeman on June 25, 2018 pursuant to the Issuer's compensation plan for non-employee directors and the Plan. F4 · derivative.exercise_date: The non-qualified stock options will vest quarterly in equal installments over two years following the date of the grant. F2 · ownership.direct: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.direct: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 16:10 UTC | BSQUARE CORP /WA BSQR · Entity 107675 | GrantCommon Stock, No Par Value | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-018305 · doc4.xml · nonDerivative · entry 1 Vardeman Ryan L. · CIK 0001574629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 F1 · shares: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F1 · price: Represents restricted stock units of BSQUARE Corporation, a Washington corporation (the "Issuer"), awarded to Ryan L. Vardeman pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer (the "Plan"). The restricted stock units will vest quarterly in equal installments over one year following the date of the award. F2 · ownership.direct: This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), and Mr. Vardeman are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund. F3 · ownership.direct: The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.